Migraine
- PMID: 41167851
- DOI: 10.1016/j.pmr.2025.08.002
Migraine
Abstract
Migraine, a common primary headache disorder, ranks second only to low back pain as a leading cause of disability. Proposed mechanisms include vasodilation, trigeminovascular activation, and neurogenic inflammation. Diagnosis is clinical, as no biomarker exists, and the International Classification of Headache Disorders-3 has clinical criteria for diagnosis. Differentiating migraine from other conditions can be challenging, with "red" and "green flags" guiding assessment. Treatment includes acute and preventive options, with calcitonin gene-related peptide inhibitors and neuromodulation as newer strategies. Complementary therapies and botulinum toxin injections may also benefit those with chronic migraine.
Keywords: Botulinum toxin; Headache; Migraine; Mindfulness; Trigeminovascular; Vasodilation.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures The contents of this work do not represent the views of the Department of the Veterans Affairs or the United States Government. The authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
